Search research articles
Contact Us
Filters
Showing results (71-80 of 156) with videos related to
Page
of 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2011
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi
Teodoro Chisesi, Monica Bellei, Stefano Luminari, et al.
Leukemia & Lymphoma
|
December 4, 2020
Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy
Alice Di Rocco, Antonio Cuneo, Arianna Di Rocco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2015
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi
Francesco Merli, Stefano Luminari, Paolo G Gobbi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2005
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi
Paolo G Gobbi, Alessandro Levis, Teodoro Chisesi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2019
A Gene Expression-based Model to Predict Metabolic Response After Two Courses of ABVD in Hodgkin Lymphoma Patients
Stefano Luminari, Benedetta Donati, Massimiliano Casali, et al.
Annals of Hematology
|
August 19, 2007
Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi
Luigi Rigacci, Umberto Vitolo, Luca Nassi, et al.
Leukemia & Lymphoma
|
January 24, 2004
The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 cases
Luigi Rigacci, Massimo Federico, Maurizio Martelli, et al.
Haematologica
|
November 21, 2007
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study
Massimo Federico, Cesare Guglielmi, Stefano Luminari, et al.
Frontiers in Oncology
|
August 3, 2023
Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020
Lucia Mangone, Domenico Penna, Francesco Marinelli, et al.
Journal of Personalized Medicine
|
February 25, 2022
HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience
Michele Clerico, Irene Dogliotti, Paola Ghione, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 156) with videos related to
Sort By:
Page
of 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2011
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi
Teodoro Chisesi, Monica Bellei, Stefano Luminari, et al.
Leukemia & Lymphoma
|
December 4, 2020
Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy
Alice Di Rocco, Antonio Cuneo, Arianna Di Rocco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 30, 2015
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi
Francesco Merli, Stefano Luminari, Paolo G Gobbi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2005
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi
Paolo G Gobbi, Alessandro Levis, Teodoro Chisesi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2019
A Gene Expression-based Model to Predict Metabolic Response After Two Courses of ABVD in Hodgkin Lymphoma Patients
Stefano Luminari, Benedetta Donati, Massimiliano Casali, et al.
Annals of Hematology
|
August 19, 2007
Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi
Luigi Rigacci, Umberto Vitolo, Luca Nassi, et al.
Leukemia & Lymphoma
|
January 24, 2004
The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 cases
Luigi Rigacci, Massimo Federico, Maurizio Martelli, et al.
Haematologica
|
November 21, 2007
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study
Massimo Federico, Cesare Guglielmi, Stefano Luminari, et al.
Frontiers in Oncology
|
August 3, 2023
Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020
Lucia Mangone, Domenico Penna, Francesco Marinelli, et al.
Journal of Personalized Medicine
|
February 25, 2022
HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience
Michele Clerico, Irene Dogliotti, Paola Ghione, et al.
Page
of 16